Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC007965 | Panoply™ Human KCNJ15 Knockdown Stable Cell Line | Inquiry |
| CSC-SC007965 | Panoply™ Human KCNJ15 Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD08422Z | Human KCNJ15 adenoviral particles | Inquiry |
| LV15991L | human KCNJ15 (NM_002243) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH323251 | shRNA set against Human KCNJ15 (NM_002243.3) | Inquiry |
| SHH323255 | shRNA set against Mouse KCNJ15 (NM_019664.4) | Inquiry |
| SHH323259 | shRNA set against Rat KCNJ15 (NM_133321.2) | Inquiry |
| SHL189182 | shRNA set against Mouse Kcnj15(NM_001039057.1) | Inquiry |
| SHL189532 | shRNA set against Human KCNJ15(NM_002243.3) | Inquiry |
| SHL189550 | shRNA set against Mouse Kcnj15(NM_001039056.1) | Inquiry |
| SHL189568 | shRNA set against Mouse Kcnj15(NM_019664.4) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCB156315 | Cynomolgus KCNJ15 ORF clone | Inquiry |
| MiUTR3H-04663 | KCNJ15 miRNA 3'UTR clone | Inquiry |
| MiUTR1M-06235 | KCNJ15 miRNA 3'UTR clone | Inquiry |
| MiUTR1M-06234 | KCNJ15 miRNA 3'UTR clone | Inquiry |
| MiUTR1M-06233 | KCNJ15 miRNA 3'UTR clone | Inquiry |
| CDFH009650 | Human KCNJ15 cDNA Clone(NM_002243.3) | Inquiry |
| CDFG010332 | Human KCNJ15 cDNA Clone(NM_170737.1) | Inquiry |
| CDFG010331 | Human KCNJ15 cDNA Clone(NM_170736.1) | Inquiry |
| CDCS410704 | Human KCNJ15 ORF Clone (BC013327) | Inquiry |
| CDCR321219 | Human KCNJ15 ORF Clone(NM_170736.1) | Inquiry |
| MiUTR3H-04664 | KCNJ15 miRNA 3'UTR clone | Inquiry |
| MiUTR3H-04665 | KCNJ15 miRNA 3'UTR clone | Inquiry |
| CDCR380698 | Rat Kcnj15 ORF Clone(NM_133321.2) | Inquiry |
| CDCR282781 | Human KCNJ15 ORF Clone(NM_002243.3) | Inquiry |
| CDCL123085 | Human Kcnj15 ORF clone (NM_001039057.1) | Inquiry |
| CDCL123083 | Mouse Kcnj15 ORF clone (NM_019664.4) | Inquiry |
| CDCL123081 | Human KCNJ15 ORF clone (NM_170737.1) | Inquiry |
| CDCB189601 | Rabbit KCNJ15 ORF clone (XM_002721258.2) | Inquiry |
Recent Research
Inward rectifier potassium (Kir) channels serve important functional and modulatory roles in a wide variety of cells. Potassium inwardly-rectifying channel, subfamily J, member 15 (KCNJ15) encodes potassium channel inward rectifiers (Kir) 4.2, which plays a role in maintaining the resting membrane potential of potassium ions close to equilibrium. The activity of KCNJ15 is directly regulated by the external potassium concentration. It is reported that KCNJ15 is frequently expressed in the brain, lung, pancreas, and whole blood. KCNJ15 is implicated as an essential factor for the secretion of insulin, brain development, and acid secretion in the lung. KCNJ15 is also expressed in the kidney. In lung epithelial cells, KCNJ15 supplies K+ to the proton pump on the apical membrane. Several studies showed that the KCNJ15 mRNA is the most highly expressed among all K+ channels in the gastric mucosa and that this channel showed a stimulation-associated translocation onto apical membrane indicative of a role for stimulated acid secretion.
In humans, KCNJ15 is closely related to type II diabetes. It has been reported that the synonymous single nucleotide polymorphism of KCNJ15 increases the risk of type II diabetes in Japanese, and the risk allele (T) is associated with increased levels of KCNJ15 mRNA in the peripheral blood of healthy volunteers. Clinical observations reveal that subjects with type II diabetes carrying the risk allele are more likely to require insulin, indicating that insulin secretion is low.
One report has revealed the mechanism of K+o-dependent regulation of Kir4.2. The K+o -dependent regulation is specific to the homomeric form of the channel and is abolished when Kir4.2 is co-expressed with Kir5.1. Different with Kir1.1, there is no coupling between the sensitivity to intracellular pH and K+o-dependent regulation of Kir4.2. Furthermore, the rate of activation is slower than the rate of inactivation (~30 min vs~2 min) and there is an inverse relationship between the rate of activation and the extracellular potassium concentration ([K+]o). Using biotinylation, it has been shown that K+o-dependent regulation does not involve a change in the surface expression of the channel, hence K+o affects the properties of the channel at the cell surface.
References: